Since 2012, the acclaimed researchers of HDRF’s Depression Task Force (DTF) have worked tirelessly to better understand the brain biology of depression in order to develop a new type of anti-depressant, one that works differently from the 20-plus drugs already on the market. Finding a new option is crucial, since 50% of patients do not respond fully to available anti-depressants.
Click here to read the full article…